Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Todo Bom

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
BMJ Open|November 9, 2019
Patient-physician discordance in assessment of adherence to inhaled controller medication: a cross-sectional analysis of two cohortsCristina Jácome, Ana Margarida Pereira, Rute Almeida, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy|November 6, 2021
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperTorsten Zuberbier, Tamara Dörr, Werner Aberer, et al.
The Journal of Allergy and Clinical Immunology|April 6, 2019
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK studyAnnabelle Bédard, Xavier Basagaña, Josep M Anto, et al.
Allergy|April 8, 2019
2019 ARIA Care pathways for allergen immunotherapyJean Bousquet, Oliver Pfaar, Alkis Togias, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
BMJ Open|November 9, 2019
Patient-physician discordance in assessment of adherence to inhaled controller medication: a cross-sectional analysis of two cohortsCristina Jácome, Ana Margarida Pereira, Rute Almeida, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy|November 6, 2021
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperTorsten Zuberbier, Tamara Dörr, Werner Aberer, et al.
The Journal of Allergy and Clinical Immunology|April 6, 2019
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK studyAnnabelle Bédard, Xavier Basagaña, Josep M Anto, et al.
Allergy|April 8, 2019
2019 ARIA Care pathways for allergen immunotherapyJean Bousquet, Oliver Pfaar, Alkis Togias, et al.
Pageof 7